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1. Introduction 
Most of the recent estrogen binding experiments 
with rat oc-fetoprotein (AFP) were considered and 
realized in relation with the well-known microhetero- 
geneity of this protein. Some differences were found 
[l] in binding capacity of the various forms, while 
essentially identical binding properties for the iso 
cY-fetoproteins were reported [2- 41. There are only 
scant reports concerning the binding of this fetal 
protein with non-steroid ligands. The presence of fatty 
acids on human AFP has been shown [5], a bilirubin 
binding site on AFP revealed [6] and interaction 
between aflatoxin B1 and AFP reported [7]. 
Binding specificity studies of AFP with various 
steroids are necessary since they provide a better 
insight in the biological role of this carcino-fetal 
globulin [8,9] particularly in comparison with the rat 
uterus estradiol receptor [lo]. Up to now very few 
quantitative data have been collected for non-estrogen 
steroids [2,11,12]. A large number of steroids has 
been investigated [ 131 by studying the diminution of 
the fluorescence of a dye bound to the protein 
(1 -aniline-naphthalene-8-sulfonate). However, this 
last method implies that competition exists between 
the dye and the steroid for the same site. 
We describe here the displacement experiments of 
bound radiolabelled estradiol with 18 steroids 
(estrogens and non-estrogens). The displacement data 
were examined using a simple linear analysis in order 
to obtain binding constants between AFP and the 
considered steroids. The obtained results provide sub- 
stantial evidence that the steroid does not necessarily 
have to contain the estratriene skeleton in order to 
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obtain binding with AFP. A strong binding (binding 
constant 107-lo8 M-l) of some 19-norandrogens to 
AFP was also observed. 
2. Materials and methods 
2.1. Chemicals 
[2,4,6,7-jH]Estradiol was purchased from the 
Radiochemical Center, Amersham. Unlabelled steroids 
were periodically tested for purity by thin-layer 
chromatography.Steroidsnumber 1,4,5.9,11,12,14,15 
and 17 (see table 1 for a complete list of steroids) 
were obtained from Sigma Chemical Co., St Louis. 
Steroids number 3,6,7.8,16 and 18 were kindly 
provided by Dr Zeelen, Organon, Oss. Steroids 
number 2 and 10 were kindly provided by Dr Pons, 
University of Montpellier. Finally steroid number 13 
was a gift of Dr Leclercq, University of Brussels. Blue 
Sepharose was purchased from Pharmacia, Uppsala. 
All the other reagents were reagent grade. 
2.2. Pwifica tion 
Rat AFP was isolated from the amniotic fluid and 
the fetal serum of Wistar rats by preparative slab gel 
electrophoresis on polyacrylamide as in [2]. Before 
electrophoresis, the crude AFP solution was passed 
through a Blue Sepharose C 1-6B column in order to 
selectively remove most of the albumin fraction. 
2.3. Binding Experiments 
The association constant for the estradiol-AFP 
interaction was obtained by equilibrium dialysis with 
Sephadex G-25, at pH 8.5 and 25”C, in a batchwise 
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fashion as in [1-,141 using radiolabelled estradiol. 
In order to determine the interactions of unlabelled 
steroids with AFP, displacement experimentsof bound 
radiolabelled estradiol were carried out. A constant 
amount of [3H]estradiol (10 or 50 pmol) and AFP 
( 150 pmol) was added to each tube containing a con- 
stant weight of Sephadex G-25 in buffer, pH 8.5. 
Various quantities of unlabelled steroid were added 
(from 50 7000 pmol) in order to displace the bound 
[3H]estradiol. From the radioactivity of the external 
volume, the amount of labelled estradiol bound to 
AFP was calculated as in [ 151. The residual binding 
was plotted against the total amount of added steroid. 
The quantity of steroid necessary to obtain, for 
example, 10% displacement was then graphically 
determined. As a result of the mass law, the equilibrium 
relationship between estradiol and the steroid for a 
single binding site is given by the following equation: 
where B = bound, F = free, K = association constant. 
The subscripts A and ES refer to steroid and radio- 
labelled estradiol, respectively. The ratio of the 
intrinsic association constants, KA/KES may be con- 
sidered as an index of cotnpetition. If K,, is known, 
the value of K, can be readily calculated from the 
slope of the linear plot, when (F/B)* is plotted in 
function of (F/BjEs. The advantage of this equation 
is to obtain in a very convenient graphical analysis 
the ratio of the binding constants. As an example of 
this plot, fig.1 illustrates the displacement of bound 
[“Hlestradiol b 3- y acetylestrone and 1 la-hydroxy- 
estrone. 
3. Results and discussion 
3.1 Binditzg data bclith estradiol 
As described [2], rat AFP binds 17P-estradiol 
maximally at pH 8.5 with an association constant of 
5 * 1 X 10’ M-l. The Scatchard plots always gave 
straight lines suggesting that AFP displays only a 
single class of binding sites (stoichlometry of 
binding 0.9 If 0.1). 
10 
5 10 
(FIBIES 
Fig.1 Competition for the estradlol bmdmg site of ArP. DIS- 
placement of bound [ ‘fl]estrad~ol with 3-acetylestronc (, ‘- ) 
and 1 la-hpdroxyestrone (0-o). Data are presented accordmg 
to the equation in section 2.3. The free/bound for the steroid 
(F/B)* IS plotted agamst the free/bound for eatradlol (F/B)l:S, 
3.2. Bimhg data with the other steroids 
In order to determine the interactions between 
AFP and several other ligands. experunents of dls- 
placement of tritiated estradiol were cal-ried out. 
Table 1 summarizes the interference of 18 derivatives 
with respect to estradiol. For convenience, the ligands 
were classified as: 
(i) Compounds which compete successfully with 
estradiol; 
(ii) Compounds which compete very poorly; 
(iii) Those which have no significant displacement 
capacity. 
However, for the last two types of compounds, a 50% 
inhibition was not reached at saturating concentra- 
tions and therefore no competition index could be 
calculated. 
First the identification of the determinant regions 
of the 2stratriene skeleton for binding with AFP was 
considered. As essential factors for estrogen binding 
we pointed out that addition of a hydroxyl group at 
position C ,(, (derivatives 11 and 12) or alkylation of 
the 17/3hydroxyl group (derivative 10) or a change in 
orientation of the C I’ hydroxyl group (derivative 14) 
result in an extensive decrease m affinity for AFP. 
On the other hand modification at position C3 (alkyla- 
tion of the hydroxyl group. derivative 2) or mtroduc- 
tion of a hydroxyl group at position C,, (comparison 
between estrone and 1 la-hydroxyestrone. derivative 3) 
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Table 1 
December 1978 
Competition between tritiated estradiol and various steroids for binding on AFP 
Steroid Number of Steroid, pmol added in order Competition Binding 
derivative to obtain 20% displacement index KAjK~s constant (M-l) 
(i) Compounds which compete 
- 
17p-Estradiol 
Estrone 
3-Acetylestrone 
1 lol-Hydroxyestrone 
Equiline 
17~Ethinylestradiol 
19-NorandrostGene-17p-01 
19-Norandrost+ene-17~01 
19-Norpregn4-ene-20S-ol 
19-Nortestosterone 
ref. 127 1 .oo 5 x 10’ 
1 107 1.85 9x 10’ 
2 129 0.95 5 x lo7 
3 213 0.33 2x lo7 
4 606 0.08 4x lo6 
5 940 0.05 3x lo6 
6 92 5.55 3x lo8 
7 775 0.06 3 x 10” 
8 125 1.04 5 x lo7 
9 1306 0.04 2x lob 
(ii) Compounds which compete poorly 
17p-Acetylestradiol 
160,17P-Estriol 
16p,l’I@Epiestriol 
17p-Estradiol-6-one(Ocarboxy- 
methyl)oxime 
17~Estradiol 
10 2000 
11 3500 
12 3500 
13 4360 
14 7000 
_ _ 
0.01 6 x lo5 
_ _ 
(iii) Compounds which do not compete 
17P-Testosterone 15 _ 
17ol-Testosterone 16 _ 
Androstadiene-3,17-dione 17 _ 
Androstd-ene-17p-01 18 _ 
does not modify extensively its binding with this fetal 
protein. Finally, modification of the estratriene 
skeleton at position C, (addition of a ketoxime group, 
derivative 13) or introduction of a C7 -Cs double 
bond (comparison between estrone and equiline, 
derivatives 1 and 4) result in an important decrease in 
affinity. However, these steroids still show some dis- 
placement capacity. Therefore, a major factor in the 
AFP-estradiol interactions resides in the integrity of 
the /3-hydroxyl configuration (change of configuration 
or alkylation). This hypothesis does not agree with 
[ 131 where it was concluded that AFP was very little 
influenced by modification of the estrogens at C r7. 
The synthesis of appropriate specific affinity labels 
for AFP should preferentially involve modifications 
of the estratriene skeleton at positions C3 or C rr. For 
example, the synthesis of an estrone-3-monohemi- 
succinateesepharose gel would be a more efficient 
affinity adsorbent for the purification of AFP as the 
7&derivative of estradiol used in [ 18,191. 
According to the well-known estrogenic binding 
properties of AFP, the importance of an aromatic 
A ring among the factors intervening in steroid 
recognition was emphasized [ 131. We observed a 
virtual lack of displacement capacity for all the chosen 
androgens with a Cr,, methyl group (derivatives 
number 15-l 8). On the other hand the nor-derivatives 
of testosterone and androst4-ene-17/3-01 (derivatives 
number 6-9) are very effective in displacing bound 
estradiol. Particularly striking is the comparison 
between androst-4-ene-17/l-01 which has no displace- 
ment capacity and its 19-nor derivative which is 
characterized by an inhibition constant of 3 X 1 OS M-' , 
greater than that of estradiol. It may also be noted, 
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similarly to that observed for the 170(- and p-isomers 
of estradiol, that the /3-enantiomer of 19norandrost- 
4-ene-17-01 is much more strongly bound to AFP than 
the oc-enantiomer. 
This study clearly shows the high affinity of some 
19-norsteroids for the estradiol binding site of AFP. 
The addition of a C1, methyl group prevents the 
binding of the androgen. In disagreement with the 
hypothesis defended [ 131, it is suggested here that 
AFP interacts strongly with 19-norandrogens where 
the A ring is no longer aromatic. As a consequence 
it would be of interest to devise affinity labels start- 
ing from the skeleton of 19+orandrogens, since these 
compounds are generally much more soluble in water 
than estrogens. 
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